GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, ALOX12, ALOX15, ALOX5, ALPI, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, FABP3, FABP4, FUT7, HMGCR, HSD11B1, HSD17B1, HSD17B2, MET, PPARA, TRPV1 |
12.7019 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, ALOX12, ALOX15, ALOX5, ALPI, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD11B1, HSD17B1, HSD17B2, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, SRC, TOP2A, TRPV1, TYR, XDH |
9.35293 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APEX1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MMP9, SRC |
8.8378 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALOX12, ALOX15, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FUT7, GLO1, HMGCR, PIM1, PPARA, TYR, XDH |
8.69522 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AXL, BCL2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP3, HMGCR, HSD17B2, IGF1R, MMP2, MMP9, NR3C1, PPARA, SRC, TRPV1, TYR |
8.4364 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, APEX1, APP, AXL, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP3, FABP4, FLT3, HMGCR, HSD17B2, IGF1R, KDR, MMP2, NR3C1, PPARA, SRC, TRPV1, TYR |
8.40591 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, AKR1B1, ALOX12, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, FABP3, FABP4, FLT3, HMGCR, HSD11B1, HSD17B1, HSD17B2, HTR1A, KDR, MET, PPARA, SRC, TRPV1, XDH |
8.39088 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, ALOX12, ALOX15, ALOX5, ALPI, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, FABP3, FABP4, FUT7, HMGCR, MET, PPARA |
7.65599 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HMGCR, HSD11B1, HSD17B1, HSD17B2 |
7.40561 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, ALOX12, ALOX15, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, HMGCR, HTR1A, TYR |
7.40561 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALOX15, APEX1, APP, AXL, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP3, FABP4, FLT3, HMGCR, HSD17B2, IGF1R, KDR, MMP2, MMP9, NR3C1, PPARA, SRC, TRPV1, TYR |
7.37922 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, ALOX12, ALOX15, ALOX5, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HMGCR, HSD11B1, HSD17B1, HSD17B2, TYR, XDH |
7.27262 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, ALOX12, ALOX15, ALOX5, ALPI, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B1, HSD17B2, HTR1A, IGF1R, KDR, MET, MMP1, MMP2, NR3C1, PIM1, PPARA, SRC, TOP2A, TYR, XDH |
6.89854 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, ALOX12, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, GLO1, HMGCR, IGF1R, KDR, MET, MMP9, PIM1, PPARA, SRC, TOP2A, TRPV1, XDH |
6.71303 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, ALOX12, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, GLO1, HMGCR, IGF1R, KDR, MET, MMP9, PIM1, SRC, TOP2A, TRPV1, XDH |
6.44266 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, ALOX12, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD2, FABP3, FLT3, HMGCR, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, SRC, TOP2A, TRPV1, XDH |
6.32786 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD11B1, HSD17B1, HSD17B2 |
6.07063 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX12, ALOX15, ALPI, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HMGCR, HSD11B1, HSD17B1, HSD17B2 |
6.07063 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.93362 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, ALOX12, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, GLO1, HMGCR, IGF1R, KDR, MMP9, PIM1, SRC, TOP2A, TRPV1, XDH |
5.73219 |
[BP] GO:0014070 |
response to organic cyclic compound
|
APEX1, APP, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, FLT3, NR3C1, SRC, TRPV1, TYR |
5.70165 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, AKR1B1, ALOX12, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD2, FABP3, FABP4, FLT3, HMGCR, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, SRC, TOP2A, TRPV1, XDH |
5.70165 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
5.61996 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, ALOX12, ALOX15, ALOX5, ALPI, APEX1, APP, AURKB, AXL, BCL2, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD11B1, HSD17B1, HSD17B2, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, SRC, TOP2A, TRPV1, TYR, XDH |
5.55242 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, HMGCR, HSD11B1, HSD17B1, HSD17B2, HTR1A |
5.53422 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, ALOX12, ALOX15, ALOX5, ALPI, APEX1, APP, AURKB, AXL, BCL2, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD11B1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, SRC, TOP2A, TRPV1, TYR, XDH |
5.53422 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX12, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1 |
5.52029 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA2, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD11B1, HSD17B2, KDR, MET, MMP2, MMP9, PIM1, PPARA, SRC, TOP2A, TYR |
5.52029 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1 |
5.51964 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1 |
5.33967 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, ALOX12, ALOX15, ALOX5, ALPI, APP, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD2, FABP4, HMGCR, HSD17B2, HTR1A, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SRC, TRPV1, TYR |
5.33967 |
[BP] GO:0042127 |
regulation of cell proliferation
|
AKR1B1, ALOX12, APP, BCL2, CSNK2A1, CYP1B1, DRD2, FABP3, FLT3, HMGCR, HTR1A, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, SRC, XDH |
5.33967 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, GLO1, HMGCR, IGF1R, KDR, MET, MMP9, PIM1, PPARA, SRC |
5.31186 |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, FLT3, HMGCR, KDR, MET, MMP12, MMP9, SRC, XDH |
5.307 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD17B1, HSD17B2 |
5.29536 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, FLT3, HMGCR, KDR, MET, MMP12, MMP9, SRC, XDH |
5.29536 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD17B1, HSD17B2 |
5.29153 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, APEX1, APP, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, NR3C1, SRC, TRPV1 |
5.2188 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, APEX1, APP, BCL2, CA2, CSNK2A1, CYP1A2, FABP3, FLT3, IGF1R, MMP2, NR3C1, PPARA, SRC, TRPV1 |
5.17434 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, GLO1, HMGCR, IGF1R, KDR, MET, MMP9, PIM1, SRC |
4.96831 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ALOX12, ALOX15, APEX1, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, HMGCR, HTR1A, IGF1R, KDR, MET, MMP12, MMP9, PPARA, SRC, TRPV1 |
4.91782 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, BCL2, CYP1A1, CYP1B1, DRD2, FABP3, HMGCR, KDR, NR3C1, SRC, TRPV1 |
4.91258 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, ALOX12, BCL2, CSNK2A1, DRD2, FLT3, HMGCR, HTR1A, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1 |
4.9063 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7 |
4.9063 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HMGCR, HSD11B1, HSD17B1, HSD17B2 |
4.9063 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, APEX1, APP, AXL, BCL2, CYP1A1, CYP1B1, FABP4, FLT3, IGF1R, KDR, MMP2, NR3C1, SRC, TRPV1 |
4.87169 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA |
4.67908 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.64739 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, APEX1, AXL, BCL2, CYP1A1, CYP1B1, DRD2, HMGCR, KDR, SRC |
4.64438 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, APEX1, BCL2, CA2, CSNK2A1, CYP1A2, FABP3, FLT3, NR3C1, PPARA, SRC, TRPV1 |
4.54739 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, DRD2, FABP3, PPARA, TRPV1 |
4.49961 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, MMP9 |
4.44842 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1 |
4.36145 |
[BP] GO:0042592 |
homeostatic process
|
AKR1B1, ALOX12, APEX1, APP, AXL, BCL2, CA12, CA2, CA7, DRD2, FABP3, FABP4, FLT3, MET, SRC, TRPV1 |
4.28072 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, GLO1, HMGCR, IGF1R, KDR, MMP9, PIM1, SRC |
4.26523 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, FLT3, HSD11B1, HSD17B2, KDR, PPARA, SRC, TYR |
4.26063 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, ALOX12, ALOX15, CYP19A1, CYP3A4, HMGCR, TYR |
4.26046 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX12, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1 |
4.20308 |
[BP] GO:0033993 |
response to lipid
|
AXL, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, FABP3, FLT3, HSD17B2, NR3C1, SRC, TYR |
4.19947 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, MMP9, SRC |
4.06645 |
[BP] GO:2001300 |
lipoxin metabolic process
|
ALOX12, ALOX15, ALOX5 |
4.0483 |
[BP] GO:0032787 |
None
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, PPARA |
4.03732 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, SRC |
4.03732 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
4.03732 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, APP, DRD2, FABP3, FLT3, IGF1R, MMP2, PPARA, SRC, TRPV1, TYR |
3.98138 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.97754 |
[BP] GO:0030334 |
regulation of cell migration
|
ALOX12, APEX1, APP, BCL2, CYP19A1, CYP1B1, DRD2, IGF1R, KDR, MET, MMP9, SRC |
3.91945 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP3, FABP4, FLT3, HMGCR, HSD17B2, HTR1A, IGF1R, KDR, MMP12, MMP2, MMP9, NR3C1, PPARA, SRC, TOP2A, TRPV1, TYR |
3.89924 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, KDR, NR3C1, SRC, TRPV1 |
3.83586 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.77931 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, FLT3, HMGCR, KDR, MET, MMP12, MMP9, SRC, XDH |
3.75324 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, NR3C1, SRC, TOP2A, TRPV1 |
3.72906 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
AKR1B1, ALOX15, APP, AXL, BCL2, CYP1B1, DRD2, FLT3, HMGCR, KDR, MET, SRC, XDH |
3.71173 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, AKR1B1, ALOX12, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD2, FABP3, FABP4, GLO1, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PIM1, PPARA, SRC, TOP2A, TRPV1, XDH |
3.68648 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, APP, DRD2, FABP3, FLT3, IGF1R, MMP2, PPARA, SRC, TRPV1, TYR |
3.68544 |
[BP] GO:2000145 |
regulation of cell motility
|
ALOX12, APEX1, APP, BCL2, CYP19A1, CYP1B1, DRD2, IGF1R, KDR, MET, MMP9, SRC |
3.68536 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPI, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, DRD2, FLT3, HMGCR, IGF1R, KDR, MET, PIM1, SRC, XDH |
3.68536 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC |
3.68536 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
BCL2, CA2, CA7, DRD2, KDR, SRC, TRPV1 |
3.65186 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, DRD2, FABP3, PPARA, TRPV1 |
3.62664 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, DRD2, HMGCR, MMP2, PPARA, SRC, TRPV1, TYR |
3.619 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPI, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DRD2, FLT3, FUT7, GLO1, HMGCR, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SRC, TOP2A, TYR, XDH |
3.57482 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, PIM1, PPARA, TYR |
3.52305 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, FLT3, HMGCR, IGF1R, KDR, MET, MMP9, SRC, XDH |
3.47794 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD2, HTR1A, TYR |
3.45665 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPI, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, DRD2, FLT3, HMGCR, IGF1R, KDR, MET, PIM1, SRC, XDH |
3.4419 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, FUT7, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
3.441 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.42491 |
[BP] GO:0040012 |
regulation of locomotion
|
ALOX12, APEX1, APP, BCL2, CYP19A1, CYP1B1, DRD2, IGF1R, KDR, MET, MMP9, SRC |
3.38963 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, AKR1B1, ALOX12, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD2, FABP3, FABP4, GLO1, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PIM1, PPARA, SRC, TOP2A, TRPV1, XDH |
3.38935 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ALOX12, APEX1, APP, BCL2, CYP19A1, CYP1B1, DRD2, IGF1R, KDR, MET, MMP9, SRC |
3.38211 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, APP, AXL, BCL2, CYP1B1, MMP9, SRC |
3.31928 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AXL, CYP1B1, IGF1R, MMP2, MMP9, NR3C1, SRC, TRPV1 |
3.28265 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, APP, FABP3, IGF1R, PPARA, SRC, TRPV1 |
3.27458 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, FLT3, HMGCR, HTR1A, IGF1R, KDR, MET, MMP12, MMP9, SRC, XDH |
3.26946 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
APEX1, APP, CYP1A1, CYP1B1, FLT3, NR3C1, SRC, TRPV1 |
3.26345 |
[BP] GO:0032844 |
regulation of homeostatic process
|
AURKB, BCL2, CA2, CA7, DRD2, HMGCR, KDR, SRC, TRPV1 |
3.25441 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, FLT3, HMGCR, HTR1A, IGF1R, KDR, MET, MMP12, MMP9, SRC, XDH |
3.19128 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, ALOX12, APP, BCL2, CA12, CA2, CA7, DRD2, FABP3, FABP4, MET, TRPV1 |
3.16971 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, PIM1, PPARA, TYR |
3.15434 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, FABP4, FLT3, HMGCR, KDR, MET, MMP12, MMP2, MMP9, SRC, XDH |
3.14465 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
3.10809 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ALOX12, APP, AXL, BCL2, CA2, CYP1B1, DRD2, HMGCR, KDR, MET, MMP12, MMP9, PIM1, SRC, TRPV1 |
3.09418 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, PIM1, PPARA, TYR |
3.08893 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, FLT3, HSD11B1, HSD17B2, KDR, MMP9, PIM1, PPARA, SRC, TYR |
3.06256 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, FLT3, HTR1A, MET, PIM1, SRC, TYR |
3.03004 |
[BP] GO:0044092 |
negative regulation of molecular function
|
APP, AURKB, CSNK2A1, CYP1B1, DRD2, FABP4, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, SRC |
3.00907 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
ALOX12, BCL2, CYP1A1, CYP1A2, CYP1B1 |
2.98566 |
[BP] GO:2001301 |
lipoxin biosynthetic process
|
ALOX12, ALOX15 |
2.98566 |
[BP] GO:2001302 |
lipoxin A4 metabolic process
|
ALOX12, ALOX15 |
2.98566 |
[BP] GO:2001303 |
lipoxin A4 biosynthetic process
|
ALOX12, ALOX15 |
2.98566 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ALOX15, BCL2, CYP1A1, DRD2, PPARA |
2.98566 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
MMP1, MMP12, MMP2, MMP9, TRPV1 |
2.91785 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, PPARA, SRC, TOP2A |
2.91305 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.9056 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, ALPI, CSNK2A1, DRD2, FABP3, FABP4, MET |
2.89372 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX12, ALOX15, ALOX5 |
2.87579 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.87484 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
2.81601 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ALOX15, APP, AXL, BCL2, CA2, CA7, CYP19A1, DRD2, HMGCR, HTR1A, MMP12, MMP9, PPARA, SRC, TRPV1 |
2.81404 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DRD2, HMGCR, KDR, SRC |
2.78384 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
AKR1B1, ALOX12, DRD2, MET, TRPV1 |
2.72036 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.71364 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.70737 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.69341 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.66881 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX12, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP3A4, HMGCR |
2.66683 |
[BP] GO:0070988 |
demethylation
|
APEX1, CYP1A1, CYP1A2, CYP3A4 |
2.65102 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ALOX12, APP, BCL2, IGF1R, KDR, MET, MMP9, SRC |
2.65102 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, HMGCR |
2.62129 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.59951 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.58577 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.56139 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ALOX12, APP, BCL2, IGF1R, KDR, MET, MMP9, SRC |
2.56139 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, SRC |
2.5439 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.51082 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ALOX12, APP, BCL2, IGF1R, KDR, MET, MMP9, SRC |
2.48216 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC |
2.46145 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.45248 |
[BP] GO:0042180 |
None
|
AKR1B1, CYP19A1, GLO1, HMGCR |
2.41813 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.40031 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ALOX12, APP, BCL2, IGF1R, KDR, MET, MMP9, SRC |
2.38507 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, APP, AURKB, AXL, BCL2, DRD2, IGF1R, KDR, MET, MMP1, MMP9, SRC |
2.37512 |
[BP] GO:0032845 |
None
|
BCL2, DRD2, HMGCR, SRC, TRPV1 |
2.3692 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.33621 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, SRC |
2.33043 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.33043 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, FABP4, MMP9 |
2.32908 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.32442 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9 |
2.28857 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ALOX15, APP, DRD2, FLT3, HMGCR, KDR, SRC, XDH |
2.28145 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, HMGCR, IGF1R, MET, MMP9, SRC, XDH |
2.24797 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.23385 |
[BP] GO:0001666 |
response to hypoxia
|
BCL2, CYP1A1, DRD2, MMP2, PPARA, SRC |
2.22652 |
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, BCL2, FLT3, FUT7, GLO1, MMP9 |
2.2102 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APEX1, APP, FLT3, IGF1R, MMP2, NR3C1, SRC, TRPV1 |
2.20453 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.20453 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2 |
2.2014 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, APP, AXL, BCL2, CBR1, CYP1A1, DRD2, FABP4, FLT3, FUT7, GLO1, HMGCR, KDR, MET, MMP2, MMP9, SRC, TOP2A |
2.18951 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
BCL2, CYP1A1, DRD2, MMP2, PPARA, SRC |
2.1686 |
[BP] GO:0051122 |
hepoxilin biosynthetic process
|
ALOX12, ALOX15 |
2.16051 |
[BP] GO:0051121 |
hepoxilin metabolic process
|
ALOX12, ALOX15 |
2.16051 |
[BP] GO:0080134 |
regulation of response to stress
|
ALOX12, APP, CYP19A1, DRD2, FABP4, HMGCR, IGF1R, MET, MMP12, MMP2, PPARA, SRC, XDH |
2.16051 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, APP, IGF1R, MMP2, SRC, TRPV1 |
2.156 |
[BP] GO:0016042 |
lipid catabolic process
|
CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
2.15447 |
[BP] GO:0006691 |
None
|
ALOX12, ALOX15, ALOX5 |
2.14421 |
[BP] GO:0010039 |
response to iron ion
|
BCL2, CYP1A1, DRD2 |
2.14421 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ALOX15, APP, AURKB, BCL2, CSNK2A1, DRD2, FLT3, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PPARA, SRC, TOP2A, TRPV1, XDH |
2.14421 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, FLT3, IGF1R, KDR, MET, SRC, TOP2A |
2.13614 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.13424 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DRD2, HMGCR, KDR, SRC |
2.13356 |
[BP] GO:0048583 |
regulation of response to stimulus
|
AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD2, FABP4, FLT3, HMGCR, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PPARA, SRC, XDH |
2.11528 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
CA2, CA7, DRD2 |
2.11528 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ALOX12, ALOX15, BCL2, CYP19A1, DRD2, HMGCR, IGF1R, MET, MMP12, MMP9, PPARA, SRC, XDH |
2.11466 |
[BP] GO:0006950 |
response to stress
|
ACHE, AKR1B1, ALOX15, APEX1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, HTR1A, MMP2, MMP9, PPARA, SRC, TOP2A, TRPV1 |
2.1071 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, FABP4, MMP9 |
2.09837 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ALOX15, APP, DRD2, FLT3, HMGCR, IGF1R, KDR, SRC, XDH |
2.08858 |
[BP] GO:0006775 |
fat-soluble vitamin metabolic process
|
CBR1, CYP1A1, CYP3A4 |
2.08452 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ALOX15, APP, BCL2, DRD2, FABP4, FLT3, HMGCR, IGF1R, KDR, MMP9, PPARA, SRC, XDH |
2.07112 |
[BP] GO:0009416 |
response to light stimulus
|
APP, AURKB, BCL2, DRD2, HMGCR, TYR |
2.05915 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ALOX15, APP, BCL2, DRD2, FABP3, FABP4, FLT3, HMGCR, IGF1R, KDR, MMP9, PPARA, SRC, XDH |
2.05334 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ALOX15, APP, BCL2, DRD2, FABP3, FLT3, HMGCR, KDR, MMP9, SRC, XDH |
2.04069 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ALOX15, APP, BCL2, DRD2, FABP3, FLT3, HMGCR, KDR, MMP9, SRC, XDH |
2.04069 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.04069 |
[BP] GO:0002933 |
lipid hydroxylation
|
CYP1A1, CYP3A4 |
2.04069 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP3A4 |
2.04069 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ALOX15, APP, BCL2, DRD2, FABP3, FABP4, FLT3, HMGCR, IGF1R, KDR, MMP9, PPARA, SRC, XDH |
2.03021 |
[BP] GO:0070482 |
response to oxygen levels
|
BCL2, CYP1A1, DRD2, MMP2, PPARA, SRC |
2.03021 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ALOX15, APP, AURKB, BCL2, CSNK2A1, DRD2, FABP3, FLT3, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PPARA, SRC, TOP2A, TRPV1, XDH |
2.02762 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, CSNK2A1, DRD2, HTR1A |
2.01485 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APEX1, APP, IGF1R, MMP2, SRC, TRPV1 |
2.00079 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, AKR1B1, ALOX12, ALOX15, ALOX5, APEX1, APP, AURKB, BCL2, CA1, CA2, CA4, CA7, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD11B1, HSD17B1, HSD17B2, KDR, MMP2, MMP9, NR3C1, PIM1, SRC, TOP2A, TRPV1, TYR, XDH |
2.97789 |
[CC] GO:0016020 |
membrane
|
ACHE, ALOX12, ALOX15, ALOX5, ALPI, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, FLT3, FUT7, GLO1, HMGCR, HSD11B1, HSD17B2, HTR1A, IGF1R, KDR, MET, MMP2, PIM1, SRC, TRPV1, TYR |
1.97237 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP |
1.81849 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FLT3, HMGCR, HSD11B1, HSD17B2 |
1.55583 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HMGCR, HSD11B1, HSD17B2 |
1.44746 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX12, ALOX15, ALOX5, ALPI, APP, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, GLO1, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, TYR, XDH |
13.6604 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX12, ALOX15, ALOX5, ALPI, APEX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, FABP3, FABP4, FLT3, GLO1, HMGCR, HSD17B1, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, SRC, TOP2A, TRPV1, TYR, XDH |
11.8484 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, AKR1B1, ALOX12, ALOX15, ALOX5, ALPI, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FLT3, FUT7, GLO1, HMGCR, HSD11B1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, SRC, TOP2A, TYR, XDH |
9.35293 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
8.53006 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALOX12, ALOX15, ALOX5, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HMGCR, HSD11B1, HSD17B1, HSD17B2, TYR, XDH |
8.4364 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX12, ALOX15, ALOX5, ALPI, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, GLO1, HTR1A, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, TOP2A, TRPV1, TYR, XDH |
7.41925 |
[MF] GO:0005506 |
iron ion binding
|
ALOX12, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, XDH |
6.54595 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7 |
6.10118 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.66572 |
[MF] GO:0046872 |
metal ion binding
|
ALOX12, ALOX15, ALOX5, ALPI, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, GLO1, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, TOP2A, TRPV1, TYR, XDH |
5.64797 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.50016 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.49856 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, GLO1 |
5.03716 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, FLT3, IGF1R, KDR, MET, PIM1, PPARA, SRC, TOP2A, TRPV1 |
5.03716 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, CBR1, HMGCR, HSD11B1, HSD17B1, HSD17B2, XDH |
4.69158 |
[MF] GO:0008270 |
zinc ion binding
|
ALPI, CA1, CA12, CA2, CA4, CA7, GLO1, MMP1, MMP12, MMP2, MMP9, NR3C1, PPARA |
4.49258 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
4.46542 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
4.3065 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.86279 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, CBR1, HMGCR, HSD11B1, HSD17B1, HSD17B2 |
3.82374 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC |
3.68369 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.54683 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC |
3.52204 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.441 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
3.27503 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HMGCR, HSD17B1, SRC, XDH |
3.19885 |
[MF] GO:0047977 |
hepoxilin-epoxide hydrolase activity
|
ALOX12, ALOX15 |
2.98566 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.9642 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, APP, BCL2, CSNK2A1, DRD2, FLT3, HMGCR, IGF1R, KDR, MET, MMP9, TOP2A, TRPV1, TYR, XDH |
2.84628 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.58577 |
[MF] GO:0004052 |
arachidonate 12-lipoxygenase activity
|
ALOX12, ALOX15 |
2.58577 |
[MF] GO:0051120 |
hepoxilin A3 synthase activity
|
ALOX12, ALOX15 |
2.58577 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, APEX1, CSNK2A1, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, SRC |
2.35739 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.33043 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.33043 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, SRC |
2.32701 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX12, ALOX15, ALOX5 |
2.32442 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD17B1, HSD17B2 |
2.28145 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX12, ALOX15, ALOX5 |
2.28145 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AXL, CYP3A4, FABP3, FABP4, HSD17B1, NR3C1, PPARA, TRPV1 |
2.23115 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD17B1, HSD17B2 |
2.20453 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.16051 |
[MF] GO:0042562 |
hormone binding
|
ACHE, HSD17B1, IGF1R, NR3C1 |
2.14421 |
[MF] GO:0051879 |
Hsp90 protein binding
|
CSNK2A1, KDR, NR3C1 |
2.11528 |
[MF] GO:0043168 |
anion binding
|
ALOX15, APP, AURKB, AXL, CSNK2A1, FABP3, FABP4, FLT3, HMGCR, HSD17B1, IGF1R, KDR, MET, PIM1, SRC, TOP2A, TRPV1, XDH |
2.05334 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP3A4 |
2.05334 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.04069 |